查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1458134

腫瘤消融的全球市場規模、佔有率和成長分析：按技術、治療和應用分類 - 產業預測（2024-2031）

Global Tumor Ablation Market Size, Share, Growth Analysis, By Technology(Radiofrequency Ablation, Microwave Ablation), By Treatment(Surgical Ablation, Laparoscopic Ablation), By Application(Kidney Cancer, Liver Cancer) - Industry Forecast 2024-2031
出版日期: | 出版商: SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2022年全球腫瘤消融市場規模將估值為14.8億美元，從2023年的16.8億美元擴大到2031年的46.3億美元，並將在預測期內（2024-2031年）成長。年複合成長率為13.5%。

推動市場擴張的兩個主要因素是癌症發生率上升和對更安全治療選擇的強烈需求。世界衛生組織（WHO）預測，到2030年，全球每年將新增1,000至1,100萬名癌症病例。低收入國家的新發癌症發生率預計將增加 80% 以上，而高所得國家的發生率預計將減半至 40%。對微創和非侵入性治療的強烈需求以及現有治療方法進步的良好潛力預計將在未來幾年推動市場發展。

在預測期內，由於外科醫生和患者對微創手術的偏好不斷增加，對先進腫瘤切除技術的需求可能會增加，因為微創手術具有縮短恢復時間、提高患者舒適度和縮短週轉時間等優點。與傳統治療相比，先進的腫瘤切除術通常作為門診病人手術進行，無需住院，因此整體費用便宜得多。對於小腫瘤，輔助手術是主要的治療策略。因此，每年的癌症檢出率對手術數量有間接影響。 2020年，由於相關部門在COVID-19期間進行的篩檢次數減少，新診斷癌症病例數有所減少，這對市場產生了重大影響。

全球變遷數據實驗室的數據世界 (OWD)舉措進行的一項研究發現，超過 70% 的癌症診斷發生在 50 歲及以上的人群中。隨著人口老化，這個數字可能會增加。老齡化人口是無創消融手術的主要目標群。因此，由於老年人口的增加，預計在預測期內對腫瘤消融手術的需求將會增加。

提高精度、攜帶性和成本經濟性的技術正在推動市場參與者不斷創新和推出尖端產品。這些技術進步包括冷凍、HIFU 和影像導引設備。使用冷卻射頻修改，即使用外部冷卻射頻探頭來擴大病變的大小，是即將到來的方法之一，預計將在市場擴張中發揮重要作用。這種治療可以使骶髂關節完全退化，從而緩解疼痛。

目錄

執行摘要

  • 市場概況
  • 轉型

調查方法

  • 資訊採購
  • 次要/一級資訊來源
  • 市場規模估算
  • 市場假設與限制

母市場分析

  • 市場概況
  • 市場規模
  • 市場動態
    • 促進因素
    • 機會
    • 抑制因素
    • 任務

主要市場考察

  • 技術分析
  • 價格分析
  • 供應鏈分析
  • 價值鏈分析
  • 市場生態系統
  • 智慧財產權分析
  • 貿易分析
  • Start-Ups分析
  • 原料分析
  • 創新矩陣
  • 研發線產品分析
  • 總體經濟指標
  • 主要投資分析
  • 關鍵成功因素
  • 競爭程度

市場動態及展望

  • 市場動態
    • 促進因素
    • 機會
    • 抑制因素
    • 任務
  • 監管環境
  • 波特的分析
  • 對未來中斷的特殊考慮

全球腫瘤消融市場：依技術分類

  • 市場概況
  • 射頻消融術
  • 微波消融
  • 冷凍
  • 不可逆電穿孔消融
  • 其他消融技術

全球腫瘤消融市場：依治療分類

  • 市場概況
  • 手術消融
  • 腹腔鏡消融術
  • 經皮消融術

全球腫瘤消融市場：依應用分類

  • 市場概況
  • 腎癌
  • 肝癌
  • 乳癌
  • 肺癌
  • 攝護腺癌
  • 其他癌症

全球腫瘤消融市場規模（按地區）

  • 市場概況
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲 (MEA)
    • 海灣合作理事會國家
    • 南非
    • 其他中東/非洲

競爭格局

  • 前5名企業對比
  • 主要企業市場定位（2021年）
  • 主要市場參與者所採取的策略
  • 關鍵成功策略
  • 近期市集活動
  • 主要企業市場佔有率（2021年）

主要企業簡介

  • Medtronic plc
  • Boston Scientific Corporation
  • Johnson & Johnson（Ethicon, Inc.）
  • AngioDynamics, Inc.
  • EDAP TMS SA
  • SonaCare Medical, LLC
  • Merit Medical Systems, Inc.
  • Misonix, Inc.
  • HealthTronics, Inc.
  • Galil Medical Ltd.
  • IceCure Medical Ltd.
  • Monteris Medical, Inc.
  • Perseon Corporation
  • NeuWave Medical（Johnson & Johnson）
  • MedWaves, Inc.
  • Hologic, Inc.
  • Sonacare Inc.（HIFU division）
  • Symple Surgical Inc.
  • BVM Medical Limited
  • Misonix, Inc.
簡介目錄
Product Code: SQMIG35A2494

Global Tumor Ablation Market size was valued at USD 1.48 Billion in 2022 and is poised to grow from USD 1.68 Billion in 2023 to USD 4.63 Billion by 2031, by rising at a CAGR 13.5% during the forecast period (2024-2031).

Two key factors propelling market expansion are the rising incidence of cancer and the strong need for safer treatment options. The World Health Organization (WHO) projects that 10-11 million new cases of cancer will be diagnosed worldwide annually by 2030. It is projected that the rate of new cancer cases in low-income countries would increase by over 80%, while the rate in high-income countries will climb at a rate of half (40%). The market is expected to be driven in the upcoming years by a strong need for minimally invasive and non-invasive therapies, as well as by lucrative potential for development in already available therapeutic choices.

Over the projection period, there will likely be an increase in demand for advanced tumor ablation technologies due to surgeons' and patients' rising preference for minimally invasive procedures because of advantages such quicker recovery times, more patient comfort, and shorter turnaround times. Advanced tumor ablation operations are significantly less expensive overall since they are typically performed as outpatient procedures without a hospital stay, in contrast to traditional therapy. For small tumors, adjuvant surgeries are the main course of treatment. Thus, annual cancer detection rates have an indirect impact on its procedure number. 2020 saw a substantial influence on the market as fewer new cancer cases were diagnosed during COVID-19 as a result of fewer screenings conducted by relevant authorities.

In a survey conducted by Global Change Data Lab's Our World in Data (OWD) initiative, people over 50 accounted for more than 70% of cancer diagnoses. The number is probably going to increase in lockstep with the aging population. When it comes to noninvasive ablation operations, the aging population is the major target group because as people age, their basic systems weaken. Therefore, over the projection period, it is anticipated that the growing aging population will increase demand for tumor ablation procedures.

Technologies that increase precision, portability, and economy of cost are what push market players to continuously innovate and introduce cutting-edge products. These technological advancements include cryoablation, HIFU, and image-guided devices. The use of the cooled radiofrequency degeneration technique with externally chilled radiofrequency probes to expand the size of the lesion is one of the forthcoming approaches that is anticipated to play a major role in market expansion. Pain can be relieved by this treatment, which permits complete degeneration of the sacroiliac joint.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Tumor Ablation Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Tumor Ablation Market Segmental Analysis

Based on end user, region, technology, and application, the global market for tumor ablation is divided into segments. The market is divided into segments according to technology: cryoablation, irreversible electroporation ablation, microwave ablation, radiofrequency ablation, and other ablation methods. The market is divided into three segments based on the type of ablation: percutaneous, laparoscopic, and surgical. The market is divided into categories for kidney cancer, liver cancer, breast cancer, lung cancer, prostate cancer, and other cancers based on the application. The global market for tumor ablation is divided into five regions: North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global Tumor Ablation Market

The market for tumor ablation is significantly influenced by the increased incidence of cancer worldwide, especially in relation to lung, liver, kidney, and breast malignancies. For patients who may not be good candidates for surgery, tumor ablation procedures provide minimally invasive alternatives to surgery for the treatment of localized tumors.

Restraints in the Global Tumor Ablation Market

Procedures for tumor ablation can be costly, particularly when cutting-edge technologies and imaging guidance are used. Tumor ablation treatments may not be as widely available in developing countries due to the high cost of specialist healthcare personnel, equipment, and consumables.

Market Trends of the Global Tumor Ablation Market

Technological Developments: The market for tumor ablation is seeing a steady stream of technological developments that are resulting in the creation of more sophisticated and accurate ablation methods. These developments include the utilization of robotic systems for increased accuracy, the creation of new energy sources for ablation, and the integration of imaging modalities for real-time guidance. Tumor ablation operations are now safer and more effective because to these technological improvements.

Growing Adoption of Minimally Invasive Procedures: Compared to standard surgical techniques, minimally invasive tumor ablation procedures are becoming more and more common. The use of minimally invasive procedures is being fueled by its benefits, which include fewer incisions, shorter hospital stays, quicker healing times, and a decreased risk of complications. As a less intrusive therapeutic alternative, minimally invasive tumor ablation techniques are becoming more and more popular among patients and healthcare professionals.

Growth in Cancer Prevalence: The market for tumor ablation is significantly influenced by the rising prevalence of cancer in the world. The increasing number of cancer cases, including those of the liver, lung, kidney, and prostate, is driving up need for efficient treatment solutions. When treating localized tumors, tumor ablation techniques present a less invasive alternatives to surgery, making them a feasible therapeutic option for patients who might not be good candidates for surgery.

Growing Interest in Precision Medicine: In oncology, precision medicine-which entails customizing treatment based on unique patient characteristics-is becoming more and more popular. Because tumor ablation techniques can target particular tumor areas while protecting healthy tissues, they are a good fit with the precision medicine principles. Tumor ablation is a desirable treatment method in the era of precision medicine because it can give targeted therapy with little effect on neighboring tissues.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Tumor Ablation Market by Technology

  • Market Overview
  • Radiofrequency Ablation
  • Microwave Ablation
  • Cryoablation
  • Irreversible Electroporation Ablation
  • and Other Ablation Technologies

Global Tumor Ablation Market by Treatment

  • Market Overview
  • Surgical Ablation
  • Laparoscopic Ablation
  • and Percutaneous Ablation

Global Tumor Ablation Market by Application

  • Market Overview
  • Kidney Cancer
  • Liver Cancer
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • and Other Cancer

Global Tumor Ablation Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • Medtronic plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson (Ethicon, Inc.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AngioDynamics, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • EDAP TMS S.A.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SonaCare Medical, LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merit Medical Systems, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Misonix, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • HealthTronics, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Galil Medical Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • IceCure Medical Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Monteris Medical, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Perseon Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NeuWave Medical (Johnson & Johnson)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MedWaves, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hologic, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sonacare Inc. (HIFU division)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Symple Surgical Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BVM Medical Limited
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Misonix, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments